Press Releases | Page 36 of 42

Behind the Study: CrkL Required for Donor T Cell Migration

February 18, 2022

Dr. Mobin Karimi from Upstate Medical University at Syracuse describes the research behind a 2020 paper he co-authored that was published by Oncotarget, entitled, “CrkL is required for donor T cell… read more

Oncotarget

Behind the Study: Oncogenic Transformation and Iron Chelation

February 7, 2022

Dr. Stephany Veuger and Dr. Gina Abdelaal from Northumbria University describe their 2021 review published by Oncotarget, entitled, “Reversing oncogenic transformation with iron chelation” Listen to an audio version of this post Behind… read more

Oncotarget

Behind the Study: Prognostic Markers in Adrenocortical Carcinoma

January 24, 2022

Dr. Monica Varun Tyagi from the Department of Surgery and Stanford Cancer Institute discusses the research paper she co-authored that was published by Oncotarget, entitled, “GATA3 and APOBEC3B are prognostic markers… read more

Oncotarget

Oncotarget’s Top 10 Most-Viewed Papers in 2021

January 21, 2022

Read the 10 most-viewed oncology-focussed papers on Oncotarget.com in 2021. — Listen to an audio version of this post #10: Metformin and berberine, two versatile drugs in treatment of common metabolic… read more

Oncotarget

Testimonial: Dr. Dean Felsher

January 20, 2022

Below is a transcript of the testimonial from Dr. Dean Felsher from Stanford University School of Medicine, Departments of Medicine and Pathology and member of Oncotarget’s Founding Editorial Board, about… read more

Dr. Brian Van Tine and Dr. Charles Schutt from Washington University in St. Louis

Oncotarget

Behind the Study: Genomic, Neoantigen Evolution in Head, Neck Cancer

January 10, 2022

Dr. Brian Van Tine and Dr. Charles Schutt from Washington University in St. Louis discuss their 2021 research published by Oncotarget, entitled, “Genomic and neoantigen evolution from primary tumor to first metastases in… read more

Oncotarget

Open-Access Oncotarget Shifts to Continuous Publishing

January 6, 2022

As of 2022, the peer-reviewed and open-access journal Oncotarget has shifted to continuous publishing. — Listen to an audio version of this announcement BUFFALO, NY, January 6, 2022 – Since its inception in… read more

Oncotarget

Behind the Study: Cholera Toxin and Age-associated Obesity

December 23, 2021

Dr. Susan Erdman from Massachusetts Institute of Technology (MIT) discusses the 2019 research paper she co-authored, entitled, “Consuming cholera toxin counteracts age-associated obesity.” Listen to an audio version of this post Behind… read more

Oncotarget

Behind the Study: Metformin and Rapamycin as Maintenance Therapy

December 13, 2021

Dr. Katherine Bever from Johns Hopkins University discusses a research paper she co-authored that was published by Oncotarget, “An exploratory study of metformin with or without rapamycin as maintenance therapy after… read more

Oncotarget

Testimonial: Dr. Jennifer Sheng

December 10, 2021

Dr. Jennifer Sheng from Johns Hopkins Sidney Kimmel Comprehensive Cancer Center shares her experience publishing "Innovating and expanding weight loss strategies for breast cancer survivors" with Oncotarget. Listen to an audio… read more